共 41 条
[1]
Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization[J]. Koen Vercauteren,Ahmed Atef Mesalam,Geert Leroux-Roels,Philip Meuleman.World Journal of Gastroenterology. 2014(43)
[3]
Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection[J] . Jean‐Michel Pawlotsky,Robert Flisiak,Shiv K. Sarin,Jens Rasenack,Teerha Piratvisuth,Wan‐Long Chuang,Cheng‐Yuan Peng,Graham R. Foster,Samir Shah,Heiner Wedemeyer,Christophe Hézode,Wei Zhang,Kelly A. Wong,Bin Li,Claudio Avila,Nikolai V. Naoumov.Hepatology . 2015 (4)
[5]
Hepatitis C virus and lipid droplets: finding a niche[J] . Ana Filipe,John McLauchlan.Trends in Molecular Medicine . 2015 (1)
[7]
Phosphatidylinositol 4,5-bisphosphate is an HCV NS5A Ligand and Mediates Replication of the Viral Genome[J] . Nam-Joon Cho,Choongho Lee,Phillip S. Pang,Edward A. Pham,Benjamin Fram,Khanh Nguyen,Anming Xiong,Ella H. Sklan,Menashe Elazar,Elif S. Koytak,Caroline Kersten,Kay K. Kanazawa,Curtis W. Frank,Jeffrey S. Glenn.Gastroenterology . 2014
[8]
Virology and cell biology of the hepatitis C virus life cycle – An update[J] . Jean Dubuisson,Fran?ois-Lo?c Cosset.Journal of Hepatology . 2014 (1)
[9]
Innate and adaptive immune responses in HCV infections[J] . Markus H. Heim,Robert Thimme.Journal of Hepatology . 2014 (1)
[10]
Natural history of hepatitis C[J] . Rachel H. Westbrook,Geoffrey Dusheiko.Journal of Hepatology . 2014 (1)